Beyond the fact that metalloproteases are pleotropic enzymes, whose inhibition will engender clinical outcomes difficult to predict, an additional concern is the accumulation of membrane-bound CD95L that, might favor the elimination of certain cancer or immune cells, but might also engender undesired tissue damage (Figure 3). Here, FASLG is linked to cancer.